| 000 | 01725 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517032635.0 | ||
| 264 | 0 | _c20151223 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1097-0215 | ||
| 024 | 7 |
_a10.1002/ijc.29605 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aButkiewicz, Dorota | |
| 245 | 0 | 0 |
_aThe VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cNov 2015 |
||
| 300 |
_a2332-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xgenetics |
| 650 | 0 | 4 |
_aWhite People _xgenetics |
| 700 | 1 | _aKrześniak, Małgorzata | |
| 700 | 1 | _aDrosik, Anna | |
| 700 | 1 | _aGiglok, Monika | |
| 700 | 1 | _aGdowicz-Kłosok, Agnieszka | |
| 700 | 1 | _aKosarewicz, Agata | |
| 700 | 1 | _aRusin, Marek | |
| 700 | 1 | _aMasłyk, Barbara | |
| 700 | 1 | _aGawkowska-Suwińska, Marzena | |
| 700 | 1 | _aSuwiński, Rafał | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 137 _gno. 10 _gp. 2332-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.29605 _zAvailable from publisher's website |
| 999 |
_c24901715 _d24901715 |
||